Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | VP, Finance and Accounting | February 28, 2025 | March 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date February 28, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,368 |
Ending reported balance
After 2025-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-02-28 · Exercise / conversion · Acquired 10,617 · Balance 58,417 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 2 · 2025-02-28 · Exercise / conversion · Acquired 15,926 · Balance 74,343 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 3 · 2025-02-28 · Exercise / conversion · Acquired 19,887 · Balance 94,230 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 4 · 2025-02-28 · Tax withholding · Disposed 17,862 · Balance 76,368 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-02-28 · Exercise / conversion · Disposed 10,617 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,927 |
Reported balance
After 2025-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-02-28 · Exercise / conversion · Disposed 15,926 · Balance 15,927 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 39,773 |
Reported balance
After 2025-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-02-28 · Exercise / conversion · Disposed 19,887 · Balance 39,773 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 19,887 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · derivative · entry 7 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,773 Underlying: Common Stock · 19,887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 15,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · derivative · entry 6 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,927 Underlying: Common Stock · 15,926 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 10,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · derivative · entry 5 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 17,862 | $0.67 | $11,967.54 |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · nonDerivative · entry 4 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,368 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 19,887 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · nonDerivative · entry 3 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 15,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · nonDerivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-007540 · form4.xml · nonDerivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 185,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005225 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,540 Underlying: Common Stock · 185,540 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:22 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 185,540 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001127602-25-005225 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,540 Underlying: Common Stock · 185,540 shares Expires 2035-02-13 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 15,927 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · derivative · entry 7 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,853 Underlying: Common Stock · 15,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 10,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · derivative · entry 6 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,617 Underlying: Common Stock · 10,616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · derivative · entry 5 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 11,793 | $2.62 | $30,897.66 |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · nonDerivative · entry 4 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,800 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 15,927 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · nonDerivative · entry 3 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · nonDerivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:33 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007629 · form4.xml · nonDerivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:19 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 59,660 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004472 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:19 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 59,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004472 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 10,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · derivative · entry 7 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,233 Underlying: Common Stock · 10,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · derivative · entry 6 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 Underlying: Common Stock · 2,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 5,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · derivative · entry 5 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 5,330 | $2.17 | $11,566.10 |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · nonDerivative · entry 4 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,350 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · nonDerivative · entry 3 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · nonDerivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:56 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007933 · form4.xml · nonDerivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 71,670 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004950 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,670 Underlying: Common Stock · 71,670 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 47,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004950 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,780 Underlying: Common Stock · 47,780 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · derivative · entry 7 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 2,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 5,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · derivative · entry 6 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 5,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · derivative · entry 5 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 3,337 | $2.85 | $9,510.45 |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · nonDerivative · entry 4 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,963 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 2,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · nonDerivative · entry 3 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 5,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · nonDerivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 3,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007177 · form4.xml · nonDerivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 31,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004757 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,850 Underlying: Common Stock · 31,850 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 47,780 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004757 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,780 Underlying: Common Stock · 47,780 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.